News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
The healthcare-plans stock is trading with an active trend, though relative strength remains moderate rather than emphatic.
UNC Health has settled two lawsuits against Humana, alleging underpayment for drugs acquired through the federal 340B discount program. The settlement was noted in North Carolina federal court, indicating the resolution of the dispute concerning the drug pricing.
Heartland Advisors Inc. reduced its stake in Humana Inc. (NYSE:HUM) by 10.6% in the first quarter, selling 2,535 shares and retaining 21,353 shares valued at $3.7 million. Other institutional investors like Watershed Asset Management and Hartford Funds Management Co LLC also made significant moves …
Sharemaestro market context Trend signal active 52 weeks +31.5%Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of investors who purchased Humana Inc. (NYSE:HUM) securities prior to June 27, 2022, and continue to hold them. The investigation focuses on whether Humana and its officers engaged in corporate wrongdoing. The firm …
Earlier this week, Humana reported that analysts have increasingly raised their earnings estimates, with the stock's analyst rating improving to a Zacks Rank #1 (Strong Buy) and sentiment strengthening around its near-term outlook. The strong agreement among analysts on higher profit expectations, especially within …
Sharemaestro market context Trend signal active 52 weeks +26.1% · Next-week setup negative 32.8%Watershed Asset Management L.L.C. recently initiated a new position in Humana Inc. (NYSE:HUM), purchasing 2,735 shares valued at approximately $474,000 during the first quarter. This aligns with a broader trend of institutional investment, as institutions now own 92.38% of Humana's stock. The insurance provider …
Humana Inc. (NYSE: HUM) stock has reached a new 52-week high of $424, marking an 82.41% increase over the past year and indicating strong investor confidence. Despite trading near its peak with an RSI suggesting it's overbought, InvestingPro analysis indicates the stock may still …
This article reports that the agreement between Wexner Medical Center and Humana is scheduled to terminate in October. No further details are provided regarding the implications or reasons for this termination.
Zacks Research has upgraded Humana (NYSE:HUM) to a "strong-buy" rating from "hold," despite the broader analyst consensus remaining at "Hold." This upgrade follows Humana's latest earnings report, which exceeded expectations with EPS of $10.31 and revenue of $39.65 billion, a 23.5% year-over-year increase. The …
The healthcare-plan stock’s latest weekly move adds to a strong three-month recovery, though participation remains lighter than its recent average.
The managed-care stock is recovering quickly, though confirmation outside price remains mixed.
The insurer’s 52-week weekly chart frames the move as a continuing recovery in healthcare plans, with confirmation still selective.
The healthcare-plan stock is still carrying strong medium-term gains, but the latest week shows pressure returning to the tape.
The healthcare-plan stock remains in an active weekly trend, but softer relative strength and a down week make the setup mixed.
The weekly setup remains active, but lighter turnover keeps the confirmation short of one-way strength.
The healthcare-plan stock is recovering strongly, but volume remains below its recent weekly norm.
The healthcare-plan stock remains in an active weekly trend, but lighter turnover keeps the confirmation less than decisive.
Humana closed at $379.20, within 0.1% of its 52-week high, as Healthcare Plans remain one of the strongest groups in US Healthcare. The advance is powerful, but the latest week came on only 0.7x normal volume.
The healthcare-plan stock is rallying, but lighter participation keeps the setup from looking one-sided.
Search by ticker symbol or company name and select a result to open its chart.